M-M-R II is a Subcutaneous Injection, Powder, Lyophilized, For Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Measles Virus Strain Enders' Attenuated Edmonston Live Antigen; Mumps Virus Strain B Level Jeryl Lynn Live Antigen; Rubella Virus Strain Wistar Ra 27/3 Live Antigen.
Product ID | 0006-4681_140f184d-dc97-40f7-96fe-a0e847ca1583 |
NDC | 0006-4681 |
Product Type | Vaccine |
Proprietary Name | M-M-R II |
Generic Name | Measles, Mumps, And Rubella Virus Vaccine Live |
Dosage Form | Injection, Powder, Lyophilized, For Suspension |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 1971-04-21 |
Marketing Category | BLA / BLA |
Application Number | BLA101069 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN |
Active Ingredient Strength | 1000 [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL |
Pharm Classes | Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],Live Attenuated Measles Virus Vaccine [EPC],Measles Vaccine [CS],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],Mumps Vaccine [CS],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [CS],Vaccines, Attenuated [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |